Intelligent Bio Solutions (NASDAQ:INBS) Issues Quarterly Earnings Results

Intelligent Bio Solutions (NASDAQ:INBS) released its earnings results on Thursday. The company reported ($0.50) EPS for the quarter, Zacks reports. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. The business had revenue of $610 billion for the quarter.

Intelligent Bio Solutions Stock Up 7.6 %

Shares of INBS stock traded up $0.18 during trading hours on Friday, reaching $2.55. The company had a trading volume of 447,850 shares, compared to its average volume of 166,171. Intelligent Bio Solutions has a 12 month low of $1.00 and a 12 month high of $5.63. The business has a fifty day simple moving average of $1.56 and a 200-day simple moving average of $1.54.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.